Rumsby G, Massoud A F, Avey C, Brook C G
Department of Chemical Pathology, UCL Hospitals, London, UK.
J Med Genet. 1996 Sep;33(9):798-9. doi: 10.1136/jmg.33.9.798.
Mutation analysis in the family of a child with 21-hydroxylase deficiency showed that the father and affected child were homozygous for a mutation, A/C655G, believed to activate a cryptic splice site in intron 2 of the 21-hydroxylase gene. The father, who was clinically asymptomatic, showed no biochemical evidence of disease. These results create problems for the management of future pregnancies in such families and for the interpretation of the risk associated with carrier status for this mutation.
对一名患有21-羟化酶缺乏症儿童的家族进行的突变分析显示,父亲和患病儿童对于一种突变(A/C655G)是纯合子,该突变被认为会激活21-羟化酶基因内含子2中的一个隐蔽剪接位点。临床无症状的父亲未显示出疾病的生化证据。这些结果给此类家庭未来妊娠的管理以及对此突变携带者状态相关风险的解读带来了问题。